Change - Announcement of Appointment::Change - Announcement of Appointment

Issuer & Securities

Issuer/ Manager
CHINA EVERBRIGHT WATER LIMITED
Securities
CHINA EVERBRIGHT WATER LIMITED - BMG2116Y1057 - U9E
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Appointment
Date &Time of Broadcast
15-Mar-2018 18:15:29
Status
New
Announcement Sub Title
Change - Announcement of Appointment
Announcement Reference
SG180315OTHR2AOW
Submitted By (Co./ Ind. Name)
An Xuesong
Designation
Executive Director and Chief Executive Officer
Effective Date and Time of the event
16/03/2018 00:00:00
Description (Please provide a detailed description of the event in the box below)
Appointment of Dr. Hao Gang as Independent Director

Additional Details

Date Of Appointment
16/03/2018
Name Of Person
HAO GANG
Age
-59
Country Of Principal Residence
Hong Kong
The Board's comments on this appointment (including rationale, selection criteria, and the search and nomination process)
Upon the recommendation of the Nominating Committee, which had reviewed the qualifications and experiences of Dr. Hao Gang, the Board of Directors has approved her appointment as an Independent Director of the Company.

The Nominating Committee of the Company, after interviewing Dr. Hao and reviewing her experience and qualifications, determined that Dr. Hao is independent in character and judgment. Dr. Hao has also confirmed that in the event of any (potential) conflict of interest arising in the course of her appointment, she will fully disclose such interest and abstain from voting (if necessary). The Board of Directors of the Company reviewed and discussed on the candidacy and independence of Dr. Hao during the Board meeting, and approved her appointment as an Independent Director of the Company.
Whether appointment is executive, and if so, the area of responsibility
Non-Executive
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Independent Director
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
None
Conflict of interests (including any competing business)
None
Working experience and occupation(s) during the past 10 years
Dr. Hao Gang has been an Associate Professor at Department of Management Sciences at College of Business, City University of Hong Kong in the past 10 years. Dr. Hao is also the Co-Director of CityU-TsinghuaU EMBA/MPA (PPP) dual degree programme at College of Business, City University of Hong Kong.

In addition to academic research and teaching, Dr. Hao has concurrently taken up the administrative role as Assistant Dean (Advancement) at College of Business, City University of Hong Kong since 2016. Prior to this, she served as an Associate Vice President (Mainland China Development) and Associate Vice President (Development) at City University of Hong Kong, Assistant Dean (International Programme and Executive Education), Director of DBA (International) and Director of EMBA (International) at College of Business, City University of Hong Kong.
Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6))
Yes
Shareholding interest in the listed issuer and its subsidiaries?
No
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).
Past (for the last 5 years)
No
Present
No
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?
No
(c) Whether there is any unsatisfied judgment against him?
No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?
No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?
No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?
No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?
No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?
No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?
No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or
No
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or
No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or
No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?
No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?
No
Any prior experience as a director of a listed company?
No
If No, Please provide details of any training undertaken in the roles and responsibilities of a director of a listed company
Dr. Hao has received relevant training to familiarise herself with the roles and responsibilities of an independent director of a listed company on the SGX-ST.